Fenghuan Sun

机构：Tongji University, Shanghai Pulmonary Hospital

发表论文 26 篇 · 总被引 1069 次 · h-index 9

代表论文

• Tumor microenvironment remodeling after neoadjuvant immunotherapy in non-small cell lung cancer revealed by single-cell RNA sequencing (2023 · Genome Medicine · 被引 400)
• Single-cell transcriptome and antigen-immunoglobin analysis reveals the diversity of B cells in non-small cell lung cancer (2020 · Genome biology · 被引 242)
• Multi-omic profiling highlights factors associated with resistance to immuno-chemotherapy in non-small-cell lung cancer (2024 · Nature Genetics · 被引 146)
• Safety and effectiveness of neoadjuvant PD-1 inhibitor (toripalimab) plus chemotherapy in stage II–III NSCLC (LungMate 002): an open-label, single-arm, phase 2 trial (2022 · BMC Medicine · 被引 68)
• Neoadjuvant Sintilimab and Chemotherapy for Resectable Stage IIIA Non-Small Cell Lung Cancer (2022 · The Annals of Thoracic Surgery · 被引 59)
• Outcomes of sleeve lobectomy versus pneumonectomy: A propensity score-matched study (2020 · Journal of Thoracic and Cardiovascular Surgery · 被引 51)